Mark S Moehle

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Parkinson Disease

Pluripotent Stem Cells

Prefrontal Cortex

Top Venues

Biochemical Society transactions

ACS pharmacology & translational science

Movement disorders : official journal of the Movement Disorder Society

Molecular psychiatry

University of Alabama at Birmingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Alabama at Birmingham

United States

PHD :: Neurology

Publications

Nicole E Chambers, Michael Millett, Mark S Moehle
The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders. Biochemical Society transactions (2023)
Mark S Moehle, Aaron M Bender, Jonathan W Dickerson, Daniel J Foster, Aidong Qi, Hyekyung P Cho, Yuping Donsante, Weimin Peng, Zoey Bryant, Kaylee J Stillwell, Thomas M Bridges, Sichen Chang, Katherine J Watson, Jordan C O'Neill, Julie L Engers, Li Peng, Alice L Rodriguez, Colleen M Niswender, Dennis C Liotta, Ellen J Hess, P Jeffrey Conn, Jerri M Rook
Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy. ACS pharmacology & translational science 4 (4) (2021)
Mark S Moehle, P Jeffrey Conn
Roles of the M4 acetylcholine receptor in the basal ganglia and the treatment of movement disorders. Movement disorders : official journal of the Movement Disorder Society 34 (8) (2019)
Samantha E Yohn, Daniel J Foster, Dan P Covey, Mark S Moehle, Jordan Galbraith, Pedro M Garcia-Barrantes, Hyekyung P Cho, Michael Bubser, Anna L Blobaum, Max E Joffe, Joseph F Cheer, Carrie K Jones, Craig W Lindsley, P Jeffrey Conn
Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators. Molecular psychiatry 25 (11) (2018)